In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Update policies package leaflet and labeling for pharmaceutical products

Update policies package leaflet and labeling for pharmaceutical products

by In2Pharma | Jan 26, 2022 | News

The Netherlands The Medicines Evaluation Board (MEB) has revised two policy documents for pharmaceutical companies on the requirements for product information: MEB 5: Package leaflet of pharmaceutical products Update sections 4, 5.1, 6, 6.2, 7, 7.1, 7.4.1 Update Annex...

Updated Annex to the EC guideline on excipients and information in the package leaflet

by In2Pharma | Dec 17, 2018 | News

EMA EMA published an updated Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’. The annex contains a list of all excipients known to have a recognised action or effect that need to be...

Recent Posts

  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA
  • Revision IML Code of Ethics
  • CBG starts authorizing temporarily different packaging

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België